Market Cap 216.13M
Revenue (ttm) 0.00
Net Income (ttm) -26.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,267,800
Avg Vol 797,126
Day's Range N/A - N/A
Shares Out 27.39M
Stochastic %K 82%
Beta 1.73
Analysts Strong Sell
Price Target $37.89

Company Profile

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I cl...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 351 4495
Address:
1975 West El Camino Real, Suite 204, Mountain View, United States
Jyoudoit
Jyoudoit Jun. 26 at 6:53 AM
$UNCY People shouting “SELL THE NEWS” need to let this sink in for a second . Needham conference, early June: “Discussions with major dialysis organizations (Fresenius, DaVita) are ongoing, with partnerships expected post-approval.” That sentence is MASSIVE. Fresenius. DaVita. The two names that actually matter in dialysis access. So the bigger picture is simple: Approval is not the end of the story. Approval may be the trigger that unlocks the real commercial headlines. Everyone is focused on the PDUFA headline, but the smarter money may be looking at what comes after: Partnerships. Launch. TDAPA. Dialysis market access. Revenue pathway. This is why the “sell the news” noise feels too small for what could be setting up here. This story has not even properly started yet. GLTYA
0 · Reply
win0rgohome
win0rgohome Jun. 26 at 4:12 AM
@Steve_TheBull_Rogers any suggestions on playing the following $UNCY, $VRDN, $ARQT, $LNTH
1 · Reply
Diverstj981
Diverstj981 Jun. 26 at 3:25 AM
$UNCY Let's hear it. Tomorrow, who's selling, who's trimming, and who's holding? I'm still undecided but having been burned on numerous post-approval pullbacks, it hard not to take some profits off the table. Up about 49%.
2 · Reply
KirkHanna
KirkHanna Jun. 26 at 1:50 AM
1 · Reply
PreslyTWO
PreslyTWO Jun. 26 at 12:07 AM
$UNCY I'm just hopping that with the Russel 3000 and the FDA ok this stock should fly. How high I'm not smart enough to figure it out. We shall see.
0 · Reply
Diverstj981
Diverstj981 Jun. 25 at 11:34 PM
0 · Reply
erictwin1
erictwin1 Jun. 25 at 10:05 PM
$UNCY Up 29 cents after hours already
1 · Reply
Legendary_Scoober
Legendary_Scoober Jun. 25 at 10:02 PM
$UNCY what if there isn’t any news Monday morning? Any chance it would be after market? I would probably sell, take the loss, or gain. So basically what I want to hear is someone telling me “not a chance, it’s approved “ lol gotta love the stock market.
2 · Reply
erictwin1
erictwin1 Jun. 25 at 9:58 PM
$UNCY Yes i think we hit 9.15 tmrw
0 · Reply
Dragan7
Dragan7 Jun. 25 at 8:59 PM
$UNCY News will come suddenly, most likely before market open. In the past: "UNCY trading has not been halted ahead of its upcoming PDUFA date"
0 · Reply
Latest News on UNCY
Unicycive Therapeutics Proxy statement: Proxy filing

Jun 22, 2026, 8:00 AM EDT - 3 days ago

Unicycive Therapeutics Proxy statement: Proxy filing


Unicycive Therapeutics files $150M mixed securities shelf

2026-06-05T20:20:10.000Z - 20 days ago

Unicycive Therapeutics files $150M mixed securities shelf


Unicycive Therapeutics Slides: Corporate presentation

Jun 4, 2026, 7:00 AM EDT - 21 days ago

Unicycive Therapeutics Slides: Corporate presentation


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:27 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:27 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:26 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:26 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:26 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:25 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:25 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:25 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:24 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Earnings release

Jun 1, 2026, 10:24 AM EDT - 24 days ago

Unicycive Therapeutics Earnings release


Unicycive Therapeutics Slides: Company presentation

May 13, 2026, 7:00 AM EDT - 6 weeks ago

Unicycive Therapeutics Slides: Company presentation


Unicycive Therapeutics reports Q1 EPS (50c), consensus (47c)

2026-05-12T11:51:45.000Z - 6 weeks ago

Unicycive Therapeutics reports Q1 EPS (50c), consensus (47c)


Unicycive Therapeutics initiated with a Buy at B. Riley

2026-05-01T14:07:09.000Z - 7 weeks ago

Unicycive Therapeutics initiated with a Buy at B. Riley


Unicycive Therapeutics management to meet with Piper Sandler

2026-02-20T14:22:23.000Z - 4 months ago

Unicycive Therapeutics management to meet with Piper Sandler


Unicycive Therapeutics initiated with a Buy at WestPark Capital

2026-02-19T12:57:38.000Z - 4 months ago

Unicycive Therapeutics initiated with a Buy at WestPark Capital


Unicycive Therapeutics resubmits NDA for oxylanthanum carbonate

2025-12-29T12:10:32.000Z - 6 months ago

Unicycive Therapeutics resubmits NDA for oxylanthanum carbonate


Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)

2025-11-12T12:21:25.000Z - 8 months ago

Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)


Unicycive Therapeutics sees cash runway into 2027

2025-11-12T12:21:01.000Z - 8 months ago

Unicycive Therapeutics sees cash runway into 2027


Unicycive Therapeutics, Inc. Announces Reverse Stock Split

Jun 17, 2025, 7:00 AM EDT - 1 year ago

Unicycive Therapeutics, Inc. Announces Reverse Stock Split


Jyoudoit
Jyoudoit Jun. 26 at 6:53 AM
$UNCY People shouting “SELL THE NEWS” need to let this sink in for a second . Needham conference, early June: “Discussions with major dialysis organizations (Fresenius, DaVita) are ongoing, with partnerships expected post-approval.” That sentence is MASSIVE. Fresenius. DaVita. The two names that actually matter in dialysis access. So the bigger picture is simple: Approval is not the end of the story. Approval may be the trigger that unlocks the real commercial headlines. Everyone is focused on the PDUFA headline, but the smarter money may be looking at what comes after: Partnerships. Launch. TDAPA. Dialysis market access. Revenue pathway. This is why the “sell the news” noise feels too small for what could be setting up here. This story has not even properly started yet. GLTYA
0 · Reply
win0rgohome
win0rgohome Jun. 26 at 4:12 AM
@Steve_TheBull_Rogers any suggestions on playing the following $UNCY, $VRDN, $ARQT, $LNTH
1 · Reply
Diverstj981
Diverstj981 Jun. 26 at 3:25 AM
$UNCY Let's hear it. Tomorrow, who's selling, who's trimming, and who's holding? I'm still undecided but having been burned on numerous post-approval pullbacks, it hard not to take some profits off the table. Up about 49%.
2 · Reply
KirkHanna
KirkHanna Jun. 26 at 1:50 AM
1 · Reply
PreslyTWO
PreslyTWO Jun. 26 at 12:07 AM
$UNCY I'm just hopping that with the Russel 3000 and the FDA ok this stock should fly. How high I'm not smart enough to figure it out. We shall see.
0 · Reply
Diverstj981
Diverstj981 Jun. 25 at 11:34 PM
0 · Reply
erictwin1
erictwin1 Jun. 25 at 10:05 PM
$UNCY Up 29 cents after hours already
1 · Reply
Legendary_Scoober
Legendary_Scoober Jun. 25 at 10:02 PM
$UNCY what if there isn’t any news Monday morning? Any chance it would be after market? I would probably sell, take the loss, or gain. So basically what I want to hear is someone telling me “not a chance, it’s approved “ lol gotta love the stock market.
2 · Reply
erictwin1
erictwin1 Jun. 25 at 9:58 PM
$UNCY Yes i think we hit 9.15 tmrw
0 · Reply
Dragan7
Dragan7 Jun. 25 at 8:59 PM
$UNCY News will come suddenly, most likely before market open. In the past: "UNCY trading has not been halted ahead of its upcoming PDUFA date"
0 · Reply
JDubbs530
JDubbs530 Jun. 25 at 8:57 PM
$UNCY any update?
0 · Reply
Tommytutones
Tommytutones Jun. 25 at 8:29 PM
$UNCY @Steve_TheBull_Rogers Hey Steve What’s our official plan for tomorrow/Monday? I know you previously posted to scale out on a big chunk of the gains, but are you holding runners? What percentage of the original trade do you think we should keep into PDUFA? thanks!
1 · Reply
erictwin1
erictwin1 Jun. 25 at 8:16 PM
$UNCY well im definately buy more shares tmrw!!!
0 · Reply
Super__Mario
Super__Mario Jun. 25 at 8:07 PM
$UNCY do we hit $9 tomorrow?
0 · Reply
Dragan7
Dragan7 Jun. 25 at 7:00 PM
$UNCY "Companies announce PDUFA results on Fridays very frequently, making it one of the most common days of the week for FDA regulatory announcements"...... Looking for over 20% price jump on 3 x ( or more ) daily average volume. This would mean street "smart money", MF, insiders families and friends loading up. GLA.....
1 · Reply
SigneAlma
SigneAlma Jun. 25 at 4:59 PM
$UNCY Unicycive schedules its GlobeNewswire distributions precisely for 7:05 AM ET. If the FDA approves OLC over the weekend or late Friday, Unicycive will lock the press release to auto-fire at this exact time on Monday morning before the pre-market volume goes into overdrive. Unicycive rarely releases news on Friday mornings because it disrupts their strategic control over the regular trading session. Releasing market-moving news at 7:00 AM on a Friday gives the market an immediate 6.5-hour live-trading window to aggressively short or wildly swing the stock right before the weekend. By Friday morning, many major institutional fund managers, investment banks, and analysts are already wrapping up their weekly portfolios. They are less likely to open massive, long-term foundational positions in a newly approved biotech stock on a Friday. Monday morning provides a clean slate where funds have a full 5-day trading week ahead to accumulate shares and drive sustained volume.
2 · Reply
Merlintrader
Merlintrader Jun. 25 at 3:03 PM
$UNCY Top priority! Russell 2026 Biotech Watchlist: , $GALT, $SPRB, $OVID and the Small-Cap Health Care Additions to Watch https://www.merlintrader.com/russell-2026-biotech-watchlist/
0 · Reply
1nvestorGadget
1nvestorGadget Jun. 25 at 2:51 PM
$UNCY We are breaking out but it has to hold. The rotation seems to be holding. We need this to continue and if the conditions remain bullish in healthcare this could absolutely go parabolic.
0 · Reply
1nvestorGadget
1nvestorGadget Jun. 25 at 2:47 PM
$UNCY Wen wake up?
0 · Reply
1nvestorGadget
1nvestorGadget Jun. 25 at 2:25 PM
$UNCY OHHH BOY ‼️
0 · Reply
Tsmith55
Tsmith55 Jun. 25 at 2:23 PM
$UNCY Would love to keep this momentum into the weekend. Approval on Monday is going to be nuts.
0 · Reply
Eagley3k
Eagley3k Jun. 25 at 2:17 PM
$UNCY Nice bullish flag forming. Shorts are trapped with only 2 trading days left. Im ready for the ride
1 · Reply